Table 1.
Summary data for histologic findings (n=40 in the training slide set)
| Gold standard |
Path 1 | Path 2 | Path 3 | Path 4 | Path 5 | Path 6 | |
|---|---|---|---|---|---|---|---|
| Max eosinophil count (mean eos/hpf ± SD) |
101 ± 107 | 72 ± 75 | 113 ± 115 | 111 ± 109 | 87 ± 94 | 77 ± 71 | 72 ± 72 |
| Mean eosinophil count (mean eos/hpf ± SD) |
53 ± 60 | 44 ± 51 | 72 ± 78 | 46 ± 46 | 41 ± 47 | 42 ± 45 | 38 ± 40 |
| Diagnostic threshold assessment (n, %) |
|||||||
| Above ≥15 eos/hpf | 27 (68) | 28 (70) | 26 (65) | 29 (73) | 26 (65) | 27 (68) | 29 (73) |
| Overdiagnosisa | -- | 2 (5) | 0 (0) | 2 (5) | 1 (3) | 1 (3) | 2 (5) |
| Underdiagnosisb | -- | 1 (3) | 1 (3) | 0 (0) | 2 (5) | 1 (3) | 0 (0) |
| Associated findings (n, %) | |||||||
| Degranulation | 27 (68) | 34 (85) | 26 (65) | 23 (58) | 28 (70) | 32 (80) | 24 (60) |
| Microabscesses | 17 (43) | 18 (45) | 19 (48) | 12 (30) | 13 (33) | 28 (70) | 26 (65) |
| Spongiosis | 29 (73) | 28 (70) | 24 (60) | 20 (50) | 32 (80) | 31 (78) | 29 (73) |
a
indicates a slide was assessed to have ≥15 eos/hpf when the gold standard did not
b
indicated a slides was assessed to have <15 eos/hpf when the gold standard had ≥15 eos/hpf